Novartis says that access to Pluvicto is now “fully unconstrained” as the pharma giant plans for manufacturing expansions to ensure a steady supply...
Novartis recently said that sales of its radiopharmaceutical Pluvicto came in lower than expected in the third quarter as a result of manufacturing issues,...
Novartis recently said that sales of its radiopharmaceutical Pluvicto came in lower than expected in the third quarter as a result of manufacturing issues,...
Researchers at MUSC Hollings Cancer Center believe that some drugs already approved by the U.S. Food and Drug Administration or currently in clinical...
CLEVELAND—Case Western Reserve University has established an Institute for Glial Sciences to advance research of glial cells and their critical role...
Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen...
WASHINGTON — Researchers have developed a new optical coherence tomography (OCT) approach that can directly image coordination of tiny hair-like structures...
A research team has discovered antibodies that could lead to a new approach to treating acute and chronic infections with the bacterium Pseudomonas aeruginosa....
The advanced therapy industry doesn’t go into details about particular assays and instruments, as they see them as proprietary and a competitive advantage...
The advanced therapy industry doesn’t go into details about particular assays and instruments, as they see them as proprietary and a competitive advantage...
The advanced therapy industry doesn’t go into details about particular assays and instruments, as they see them as proprietary and a competitive advantage...
The advanced therapy industry doesn’t go into details about particular assays and instruments, as they see them as proprietary and a competitive advantage...
The advanced therapy industry doesn’t go into details about particular assays and instruments, as they see them as proprietary and a competitive advantage...
Urothelial cancer oncologist Matthew Galsky has trouble remembering the last time there was a standing ovation for clinical trial data at a medical conference....
Just over a month before the FDA makes a landmark decision about the first-ever therapy to use CRISPR/Cas9 gene editing, the agency is paying close attention...
Viral vector manufacturer ViroCell Biologics is leasing its first-ever facility — located at Great Ormond Street Hospital in London — so it can offer...
Imagine the body’s cells are well-behaved students in the classroom. The “teachers” are tumor suppressor genes, and they make sure cells follow the...
Recent preclinical results indicate novel next-generation vaccine candidates developed at Cleveland Clinic protect against multiple strains of influenza...
Researchers at the University of Wisconsin–Madison and Academia Sinica of Taiwan have harnessed a combination of lab-grown cells to regenerate damaged...
Researchers developed an approach to cancer treatment that uses dimeric IgA antibodies to target and kill tumor-promoting molecules found deep within cancer...
BINGHAMTON, N.Y. — A new drug developed by professors from the School of Pharmacy and Pharmaceutical Sciences at Binghamton University has received Food...
In the late 1970s, the relationship between the c-Src gene and cancer was discovered. The first oncogene was identified. Credit: Esther Sánchez / CNIO...
British drugmaker GSK plans to acquire an experimental hepatitis B drug from Johnson & Johnson and its developer Arrowhead Pharmaceuticals and then...
At 18 Spanish hospitals, when a patient with brain metastasis undergoes surgery, they can donate a tiny part of their brain to the first repository of...
Registration and abstracts are open for the ISSCR 2024 Annual Meeting, where academic and industry innovators in stem cell science and regenerative medicine...
UC, UC Health mark 10 years as NIH StrokeNet National Coordinating Center, celebrate competitive renewal for next 5 years Credit: University of Cincinnati...
DURHAM, N.C. — For too long, cancer treatment has been a double-edged sword – the very treatments designed to kill cancer cells often wrought havoc...
MapLight Therapeutics has raised a $225 million round to enter Phase II clinical trials in schizophrenia and Alzheimer’s disease psychosis and run an...
COVID-19 mRNA Vaccines Reduce A Major Beneficial Bacteria, Gut Biodiversity: Research Authored by Marina Zhang via The Epoch Times (emphasis...
Fyodor Urnov, PhD, is a pioneer in the field of genome editing and one of the scientists most invested in expanding the availability and utility of...